期刊文献+

艾司西酞普兰与西酞普兰治疗抑郁症对比研究 被引量:8

The efficacy and side effects of escitalopram in the treatment of depression
下载PDF
导出
摘要 目的:探讨艾司西酞普兰治疗抑郁症的疗效及不良反应。方法:将80例抑郁患者随机分为艾司西酞普兰组和西酞普兰组,每组40例,分别给予艾司西酞普兰或西酞普兰治疗。两组疗程均为6周,采用汉密尔顿抑郁量表(HAMD)、临床总体印象量表(CGI)评判疗效,Asberg氏抗抑郁剂副反应量表(SERS)评定不良反应,比较两组临床疗效和不良反应。结果:艾司西酞普兰的总有效率为92.5%,西酞普兰的总有率为75.0%,艾司西酞普兰的临床效果明显优于西酞普兰,差异有统计学意义(P<0.05)。结论:艾司西酞普兰是治疗抑郁症高效、安全的药物。 Objective To investigate the efficacy and side effects of escitalopram in the treatment of depression.Methods 80 cases of depression were randomly divided into escitalopram group and citalopram group,each group of 40 patients.The treatment lasted 6 weeks.80 cases of depression were assessment with Hamilton Depression Rating Scale(HAMD),Clinical Global Impression Scale(CGI),Asberg’s antidepressant side effects scale(SERS).Results The total effective rate of escitalopram group(92.5%) is higher than that of citalopram group(75.0%).Escitalopram is superior to citalopram in the clinical effects(P0.05).Conclusion Escitalopram is effective and safe in the treatment of depression.
出处 《吉林医学》 CAS 2013年第24期4871-4872,共2页 Jilin Medical Journal
关键词 抑郁症 艾司西酞普兰 西酞普兰 Depression Escitalopram Citalopram
  • 相关文献

参考文献10

二级参考文献63

共引文献190

同被引文献63

  • 1任晓艳.穴位埋线的源流及其机理探讨[J].中国医药学报,2004,19(12):757-759. 被引量:389
  • 2中风病诊断与疗效评定标准(试行)[J].北京中医药大学学报,1996,19(1):55-56. 被引量:5991
  • 3张亚同,傅得兴.艾司西酞普兰的药理及临床评价[J].中国新药杂志,2006,15(22):1979-1983. 被引量:46
  • 4沈渔邨.精神病学[M].第5版.北京:人民卫生出版社,2009:215.
  • 5中华医学会精神科分会.中国精神障碍分类与诊断标准[M].3版.济南:山东科学技术出版社,2001:108-1150.
  • 6Meesters PD,de Haan L,Comijs HC,et al.Schizophrenia spectrum disorders in later life:prevalence and distribution of age at onset and sex in a Dutch catchment area[J].Am J Ger Psychiatry,2012,20:18-28.
  • 7Riedel M,Mayr A,Seemüller F,et al.Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients:comparing treatment with risperidone and haloperidol[J].World J Biol Psychiatry,2012,13:30-38.
  • 8Khan A,Faucett J,Morrison S,et al.Comparative mortality risk in adult patients with Schizophrenia,depression,bipolar disorder,anxiety disorders,and attention-deficit/hyperactivity disorder participating in Psychopharmacology Clinical Trials[J].JAMA psychiatry,2013,70:1091-1099.
  • 9Araragi N,Lesch KP.Serotonin(5-HT)in the regulation of depression-related emotionality:insight from 5-HT transporter and tryptophan hydroxylase-2 knockout mouse models[J].Curr Drug Targets,2013,14:549-570.
  • 10Pujia F,Serrao M,Brienza M,et al.Effects of a selective serotonin reuptake inhibitor escitalopram on the cutaneous silent period:A randomized controlled study in healthy volunteers[J].Neurosci Lett,2014,566:17-20.

引证文献8

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部